main-logo

ICD-10 Code C81.21 | Mix cellular Hdgkn lymph, nodes of head, face, and nk Symptoms, Diagnosis, Billing

Mix cellular Hodgkin lymphoma is a subtype of Hodgkin lymphoma characterized by a mixture of cell types in the lymph nodes, particularly affecting the nodes of the head, face, and neck. This condition is clinically significant due to its potential for systemic symptoms and progression if left untreated. The ICD-10 Code C81.21 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code C81.21 for Mix cellular Hdgkn lymph, nodes of head, face, and nk?

ICD-10 Code C81.21 represents Mix cellular Hodgkin lymphoma affecting the lymph nodes of the head, face, and neck. This condition is a malignancy of the lymphatic system, often presenting with lymphadenopathy and systemic symptoms. This code should be used in clinical documentation and billing when diagnosing patients with this specific subtype of Hodgkin lymphoma to ensure accurate treatment and reimbursement.

ICD-10 Code C81.21 – Clinical Definition and Explanation of Mix cellular Hdgkn lymph, nodes of head, face, and nk

Mix cellular Hodgkin lymphoma is caused by the abnormal proliferation of lymphocytes, leading to the formation of tumors in lymph nodes, particularly in the head, face, and neck regions. The condition can progress rapidly and requires prompt medical attention to prevent complications.

Key Clinical Features:

  • Painless lymphadenopathy in the head and neck region.
  • Systemic symptoms such as fever, night sweats, and weight loss.
  • Potential for mediastinal involvement and respiratory symptoms.
  • Histological confirmation through biopsy showing mixed cellularity.

ICD-10 Code C81.21 for Mix cellular Hdgkn lymph, nodes of head, face, and nk – SOAP Notes & Clinical Use

ICD-10 Code C81.21 is utilized in SOAP notes to document the diagnosis of Mix cellular Hodgkin lymphoma. It plays a crucial role in capturing symptoms, assessments, and treatment plans, relevant in both acute and chronic care settings.

What Does ICD-10 Code C81.21 for Mix cellular Hdgkn lymph, nodes of head, face, and nk Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C81.21 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Mix cellular Hodgkin lymphoma, ensuring continuity of care and supporting accurate billing while meeting EHR documentation standards.

Treatment Options for ICD-10 Code C81.21 – Mix cellular Hdgkn lymph, nodes of head, face, and nk

Prompt treatment for Mix cellular Hodgkin lymphoma is essential to manage the disease effectively.

Antibiotic Therapy:

  • Not applicable as this is not an infectious condition.

Supportive Care:

  • Symptom management including pain relief and nutritional support.
  • Psychosocial support for patients and families.
  • Monitoring for treatment side effects.

Infection Control:

  • Standard precautions to prevent infections during treatment.
  • Education on hygiene practices for immunocompromised patients.

How to Document Symptoms of Mix cellular Hdgkn lymph, nodes of head, face, and nk (ICD-10 C81.21) in SOAP Notes

Subjective:

  • Patient reports painless swelling in the neck.
  • Experiencing night sweats and unintentional weight loss.
  • History of fatigue and recurrent fevers.

Objective:

  • Physical examination reveals enlarged cervical lymph nodes.
  • Vital signs show mild fever (100.5°F).
  • Biopsy results confirm mixed cellularity in lymph node tissue.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Mix cellular Hdgkn lymph, nodes of head, face, and nk (ICD-10 Code C81.21)

Assessment:

  • Diagnosis: Mix cellular Hodgkin lymphoma, stage II.
  • ICD-10 Code: C81.21.
  • Contributing factors: History of lymphadenopathy and systemic symptoms.

Plan:

  • Initiate chemotherapy regimen as per oncology guidelines.
  • Schedule follow-up appointments for monitoring response to treatment.
  • Educate patient on potential side effects and supportive care measures.

Treatment & Plan Section for ICD-10 Code C81.21 – Mix cellular Hdgkn lymph, nodes of head, face, and nk

  • First-line treatment typically includes ABVD chemotherapy regimen.
  • Consider radiation therapy for localized disease after chemotherapy.
  • Regular follow-up with imaging studies to assess treatment response.
  • Patient education on lifestyle modifications and symptom management.

Using ICD-10 Code C81.21 for Mix cellular Hdgkn lymph, nodes of head, face, and nk in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
  • Use C81.21 for billing when diagnosing and treating this specific lymphoma subtype.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Include relevant CPT codes for chemotherapy administration and follow-up visits.

ICD-10 Code C81.21 in Medical Billing and Insurance for Mix cellular Hdgkn lymph, nodes of head, face, and nk

ICD-10 Code C81.21 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

  • Document all relevant clinical findings and treatment plans to support claims.
  • Use C81.21 in conjunction with appropriate CPT codes for accurate billing.
  • Ensure that documentation reflects the severity and complexity of the condition.

Common CPT Pairings:

CPT CodeDescription
96413Chemotherapy administration, intravenous, push technique.
99214Established patient office visit, moderate complexity.
85025Complete blood count with differential.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C81.21 for Mix cellular Hdgkn lymph, nodes of head, face, and nk

What are the common symptoms of Mix cellular Hodgkin lymphoma?

Common symptoms include painless swelling of lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.

How is Mix cellular Hodgkin lymphoma diagnosed?

Diagnosis typically involves a physical examination, imaging studies, and a biopsy of the affected lymph nodes to confirm the presence of Hodgkin lymphoma cells.

What treatment options are available for this condition?

Treatment usually includes chemotherapy, and in some cases, radiation therapy may be recommended. The specific regimen depends on the stage and individual patient factors.

Is Mix cellular Hodgkin lymphoma contagious?

No, Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and cannot be transmitted from person to person.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved